Like a great orchestra, your brain relies on the perfect coordination of many elements to function properly. And if one of those elements is out of sync, it affects the entire ensemble. In Alzheimer’s disease, for instance, damage to specific neurons can alter brainwave rhythms and cause a loss of cognitive functions.
One type of neuron, called inhibitory interneuron, is particularly important for managing brain rhythms. It’s also the research focus of a laboratory led by Jorge Palop, PhD, assistant investigator at the Gladstone Institutes. In a study published in Neuron, Palop and his collaborators uncovered the therapeutic benefits of genetically improving these interneurons and transplanting them into the brain of a mouse model of Alzheimer’s disease.
Interneurons control complex networks between neurons, allowing them to send signals to one another in a harmonized way. You can think of inhibitory interneurons as orchestra conductors. They create rhythms in the brain to instruct the players—excitatory neurons—when to play and when to stop. An imbalance between these two types of neurons creates disharmony and is seen in multiple neurological and psychiatric disorders, including Alzheimer’s disease, epilepsy, schizophrenia, and autism.
A Brain without a Conductor
Palop’s previous studies showed that, in mouse models of Alzheimer’s, the inhibitory interneurons do not work properly. So, the rhythms that organize the excitatory cells are disturbed and fail to function harmoniously, causing an imbalance in brain networks. This, in turn, affects memory formation and can lead to epileptic activity, which is often observed in patients with Alzheimer’s disease.
His team found a way to reengineer inhibitory interneurons to improve their function. They showed that these enhanced interneurons, when transplanted into the abnormal brain of Alzheimer mice, can properly control the activity of excitatory cells and restore brain rhythms.
“We took advantage of the fact that transplanted interneurons can integrate remarkably well into new brain tissues, and that each interneuron can control thousands of excitatory neurons,” said Palop, who is also an assistant professor of neurology at the University of California, San Francisco. “These properties make interneurons a promising therapeutic target for cognitive disorders associated with brain rhythm abnormalities and epileptic activity.”
First, the scientists had to overcome a significant challenge. When they transplanted regular interneurons, they saw no beneficial effects, presumably because Alzheimer’s disease creates a toxic environment in the brain.
The researchers then genetically boosted the activity of inhibitory interneurons by adding a protein called Nav1.1. They discovered that the interneurons with enhanced function were able to overcome the toxic disease environment and restore brain function.
“These optimized neurons are like master conductors,” said Palop. “Even with a declining orchestra, they can restore the rhythms and harmony needed for cognitive functions.”
Conductors Engineered for Alzheimer’s Disease
The findings could eventually lead to the development of new treatment options for patients with Alzheimer’s disease.
“Besides the applications this cell engineering and transplantation approach may find in regenerative medicine, our findings support the broader concept that enhancing the function of interneurons can counteract key aspects of Alzheimer’s disease,” said Lennart Mucke, MD, director of the Gladstone Institute of Neurological Disease.
In addition to examining if the cell therapy could be translated from mice to humans, Palop and his team are working to identify potential drugs as an alternative way to enhance the function of inhibitory interneurons.
The Latest on: Alzheimer’s Disease
via Google News
The Latest on: Alzheimer’s Disease
- Alzheimer’s Disease Diagnostic Market Size, Share, Trends, Major Drivers, Segments and Regional Analysis with Forecast to 2022 on December 19, 2018 at 2:51 am
Market Research Future released a new research report named as “Alzheimer’s disease Diagnostic Market” with forecast up to 2022. Report included Exclusive analysis by Industry Experts from most repute... […]
- 12 Days of Charitable Giving 2018: Cure Alzheimer's Fund on December 18, 2018 at 6:50 pm
was founded in 2004 by three families who wanted to provide funding for Alzheimer’s disease research. Alzheimer’s disease is defined as an irreversible, progressive disorder that results in the physic... […]
- Scientists Pave Way for Saliva Test for Alzheimer's Disease on December 18, 2018 at 4:46 pm
University of Alberta scientists have identified three biomarkers for detecting mild cognitive impairment and Alzheimer's disease in saliva samples. The research has promising results for application ... […]
- Alzheimer’s Protein May Be Transmissible, in Rare Cases on December 18, 2018 at 2:58 pm
Aβ pathology is a hallmark of cerebral amyloid angiopathy (CAA) and Alzheimer’s disease (AD). Several of the patients displayed pathology resembling CAA; however, none met the full neuropathological c... […]
- Wiring diagram of brain reconciles inconsistent neuroimaging findings of Alzheimer’s patients on December 18, 2018 at 1:46 pm
For their study, Fox and colleagues evaluated results from 26 neuroimaging studies of Alzheimer’s disease patients. Specifically, the studies investigated abnormalities in structure, metabolism or cir... […]
- A father, stricken with a rare form of Alzheimer's, fears for his daughter on December 18, 2018 at 11:27 am
Earlier this year, he also helped organize a conference that brought U.S.-based Alzheimer’s experts to Mexico to discuss the disease. It was the first time some people realized what they and their rel... […]
- Alzheimer's Disease: A Brain Cell That May Make You Susceptible on December 18, 2018 at 11:12 am
A particular type of brain cell may play a key role in making you vulnerable to Alzheimer’s disease, according to a study out of the Ohio State University. The OSU researchers found that the excitator... […]
- New Study Reveals Half of NJ residents Diagnosed with Alzheimer's Disease Do Not Receive Referrals to Support Services on December 18, 2018 at 8:05 am
ROSELAND – A recent survey conducted by Fairleigh Dickinson University’s PublicMind on behalf of Alzheimer’s New Jersey® found that an overwhelming majority of New Jersey residents with memory loss co... […]
- Public supports NIH grants for Alzheimer's microbes, reports Alzheimer's Germ Quest, Inc. on December 18, 2018 at 6:32 am
"The big surprise so far is that many people thought NIH already had funded investigations of every possible infectious agent in searching for the unknown trigger of Alzheimer's disease," says Dr ... […]
via Bing News